Review



cftr  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems cftr
    (a & b) Representative I sc tracings of <t>CFTR-dependent</t> short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR <t>and</t> <t>β2AR</t> expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.
    Cftr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 132 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr/product/R&D Systems
    Average 93 stars, based on 132 article reviews
    cftr - by Bioz Stars, 2026-05
    93/100 stars

    Images

    1) Product Images from "PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling"

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    Journal: bioRxiv

    doi: 10.64898/2026.04.21.719931

    (a & b) Representative I sc tracings of CFTR-dependent short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR and β2AR expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.
    Figure Legend Snippet: (a & b) Representative I sc tracings of CFTR-dependent short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR and β2AR expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.

    Techniques Used: Western Blot, Expressing, Control

    Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of B[a]P. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.05; ** p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a ).
    Figure Legend Snippet: Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of B[a]P. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.05; ** p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a ).

    Techniques Used: Incubation, Control, Western Blot, Expressing

    Cells were treated with various concentrations of PM2.5 for 24 hr. ( a ) Cell viability was assessed with MTT assay. ( b ) IL-6 and IL-8 from the basolateral sides. ( c ) Representative Western blot images showing CFTR, β2AR, phospho-AKT (Ser473), AKT, phospho-NF-κB p65 (Ser536), NF-κB p65, and TRPC6 expression. All data are presented as the mean ± SD (n = 4). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; *, p < 0.05; ¥, p < 0.01; NS, no significance.
    Figure Legend Snippet: Cells were treated with various concentrations of PM2.5 for 24 hr. ( a ) Cell viability was assessed with MTT assay. ( b ) IL-6 and IL-8 from the basolateral sides. ( c ) Representative Western blot images showing CFTR, β2AR, phospho-AKT (Ser473), AKT, phospho-NF-κB p65 (Ser536), NF-κB p65, and TRPC6 expression. All data are presented as the mean ± SD (n = 4). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; *, p < 0.05; ¥, p < 0.01; NS, no significance.

    Techniques Used: MTT Assay, Western Blot, Expressing, Control

    Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of PM 2.5. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 6). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a). All Western analyses represent the results of three independent experiments, and β-actin was used for equal loading of protein.
    Figure Legend Snippet: Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of PM 2.5. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 6). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a). All Western analyses represent the results of three independent experiments, and β-actin was used for equal loading of protein.

    Techniques Used: Incubation, Control, Western Blot, Expressing

    (a) Representative Western blot images of cell surface CFTR and β2AR expression in cells treated with DMSO or various concentrations of B[a]P. (b & c) Recycling assay of endocytosis CFTR and β2AR were analyzed by Western blot. Representative Western blot images of biotinylated CFTR and β2AR expression are shown. Cell samples treated without or with GSH ( lanes 1 and 2 ) were used as positive controls for biotinylation and GSH stripping processes, respectively. (d) A representative Western blot image showing ubiquitination of CFTR immunoprecipitates from cell lysates treated with different concentrations of B[a]P in the presence of 20 µM MG 132. All Western blot analyses represent the results of three independent experiments.
    Figure Legend Snippet: (a) Representative Western blot images of cell surface CFTR and β2AR expression in cells treated with DMSO or various concentrations of B[a]P. (b & c) Recycling assay of endocytosis CFTR and β2AR were analyzed by Western blot. Representative Western blot images of biotinylated CFTR and β2AR expression are shown. Cell samples treated without or with GSH ( lanes 1 and 2 ) were used as positive controls for biotinylation and GSH stripping processes, respectively. (d) A representative Western blot image showing ubiquitination of CFTR immunoprecipitates from cell lysates treated with different concentrations of B[a]P in the presence of 20 µM MG 132. All Western blot analyses represent the results of three independent experiments.

    Techniques Used: Western Blot, Expressing, Stripping Membranes, Ubiquitin Proteomics

    ALI cells were treated with DMSO, 100 ng/mL PM 2.5, 10 µM LY 294002 ± PM 2.5, or 10 µM LY 303511 ± PM 2.5 for 24 hrs. ( a ) IL-6 and IL-8 from the basolateral sides were determined using the DuoSet® ELISA kits. Data are presented as the mean ± SD (n=3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing all treatments to the DMSO control, or PM 2.5 to PM 2.5 ± LY 294002 or LY 303511; *, p < 0.01. ( b ) Representative Western blot images showing CFTR and β-actin expression. β-actin was used to ensure equal loading of protein. All data were obtained from three independent experiments, and each experiment was analyzed in duplication.
    Figure Legend Snippet: ALI cells were treated with DMSO, 100 ng/mL PM 2.5, 10 µM LY 294002 ± PM 2.5, or 10 µM LY 303511 ± PM 2.5 for 24 hrs. ( a ) IL-6 and IL-8 from the basolateral sides were determined using the DuoSet® ELISA kits. Data are presented as the mean ± SD (n=3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing all treatments to the DMSO control, or PM 2.5 to PM 2.5 ± LY 294002 or LY 303511; *, p < 0.01. ( b ) Representative Western blot images showing CFTR and β-actin expression. β-actin was used to ensure equal loading of protein. All data were obtained from three independent experiments, and each experiment was analyzed in duplication.

    Techniques Used: Enzyme-linked Immunosorbent Assay, Control, Western Blot, Expressing

    ( a ) Fluo-4-AM fluorescence intensity traces obtained 24 hours after treatment with B[a]P and stimulated with assay buffer containing 1 mM Ca +2 . ( b ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 1 mM Ca +2 . ( c & d ) Representative Western blot images of β2AR and TRPC6 expression levels in treated cell in ( a ) and respective densitometric analyses. ( e ) The Pearson correlation coefficient (r) showing a significant negative relationship between β2AR and TRPC6 expression caused by B[a]P treatment. ( f ) Fluo-4AM fluorescence intensity traces in 16HBE14o-cells were obtained before and after addition of 2 mM Ca +2 in the presence or absence of 5µM BI 749327. ( g ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 2 mM Ca +2 . ( h ) Representative western blotting analyses of CFTR expression in corresponding treated cells. All data represent the mean of three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P ± BI 749327 treatments to the DMSO control; ¥, p<0.05, * p < 0.01.
    Figure Legend Snippet: ( a ) Fluo-4-AM fluorescence intensity traces obtained 24 hours after treatment with B[a]P and stimulated with assay buffer containing 1 mM Ca +2 . ( b ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 1 mM Ca +2 . ( c & d ) Representative Western blot images of β2AR and TRPC6 expression levels in treated cell in ( a ) and respective densitometric analyses. ( e ) The Pearson correlation coefficient (r) showing a significant negative relationship between β2AR and TRPC6 expression caused by B[a]P treatment. ( f ) Fluo-4AM fluorescence intensity traces in 16HBE14o-cells were obtained before and after addition of 2 mM Ca +2 in the presence or absence of 5µM BI 749327. ( g ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 2 mM Ca +2 . ( h ) Representative western blotting analyses of CFTR expression in corresponding treated cells. All data represent the mean of three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P ± BI 749327 treatments to the DMSO control; ¥, p<0.05, * p < 0.01.

    Techniques Used: Fluorescence, Western Blot, Expressing, Control

    ( a ) After 24 hr treatment, fluorescence intensity traces obtained using the fluo-4 AM when DMSO- or PM 2.5-treated 16HBE14o-cellswere stimulated with assay buffer containing 2 mM Ca. Each trace is the mean of three independent experiments with standard deviations (vertical bars). ( b ) Corresponding histograms summarize the mean area under the curve (AUC) after stimulation by 2 mM Ca. ( c ) Representative Western blot images of CFTR, β2AR and TRPC6 expression levels in treated cell in ( a ). All data were obtained from four independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the PM 2.5 treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01.
    Figure Legend Snippet: ( a ) After 24 hr treatment, fluorescence intensity traces obtained using the fluo-4 AM when DMSO- or PM 2.5-treated 16HBE14o-cellswere stimulated with assay buffer containing 2 mM Ca. Each trace is the mean of three independent experiments with standard deviations (vertical bars). ( b ) Corresponding histograms summarize the mean area under the curve (AUC) after stimulation by 2 mM Ca. ( c ) Representative Western blot images of CFTR, β2AR and TRPC6 expression levels in treated cell in ( a ). All data were obtained from four independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the PM 2.5 treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01.

    Techniques Used: Fluorescence, Western Blot, Expressing, Control

    ( a ) The lung parenchyma from two ferrets were sliced into several sections as shown. Arrows indicate the tracheobronchial tubes. All tissue sections were incubating with DMSO (control), 10 µM B[a]P, or 100 ng/mL PM 2.5 in Pneumacult-EX Plus Basal media for 24 hrs. ( b ) IL 6 secretion was determined using the ferret ELISA kit. Data represent the mean of 6 independent sections. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; ¥, p < 0.05 (n = 6). ( c ) Representative western blotting images show reduction of CFTR, and β2AR and elevation of TRPC6 expression in explants under these treatments.
    Figure Legend Snippet: ( a ) The lung parenchyma from two ferrets were sliced into several sections as shown. Arrows indicate the tracheobronchial tubes. All tissue sections were incubating with DMSO (control), 10 µM B[a]P, or 100 ng/mL PM 2.5 in Pneumacult-EX Plus Basal media for 24 hrs. ( b ) IL 6 secretion was determined using the ferret ELISA kit. Data represent the mean of 6 independent sections. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; ¥, p < 0.05 (n = 6). ( c ) Representative western blotting images show reduction of CFTR, and β2AR and elevation of TRPC6 expression in explants under these treatments.

    Techniques Used: Control, Enzyme-linked Immunosorbent Assay, Western Blot, Expressing

    PM 2.5 or the PM 2.5 toxin B[a]P initially acts as an irreversible β2AR agonist to hyperactivate the PI3K signaling pathway. PLC, acting on PIP2, releases DAG. DAG activates the TRPC6 channel to bring extracellular Ca +2 into the cell. Increased Ca +2 is taken up by mitochondria, which release Reactive Oxygen Species (ROS) and contribute to oxidative stress. BI 749327 can block TRPC6 channel activity and suppress oxidative stress. Meanwhile, hyper-activation of β2AR leads to endosomal β2AR loss, followed by endosomal loss of CFTR (-). Loss of CFTR results in (i) activation of TRADD and downstream activation of IKKαβ to drive NFκB; and (ii) further activation of CFTR-bound TRPC6. NFκB enters the nucleus and drives expression of proinflammatory cytokines IL8 and IL6. Both TRADD and PI3K pathways may be required for optimal NFκB activation, because LY294002 can block inflammation.
    Figure Legend Snippet: PM 2.5 or the PM 2.5 toxin B[a]P initially acts as an irreversible β2AR agonist to hyperactivate the PI3K signaling pathway. PLC, acting on PIP2, releases DAG. DAG activates the TRPC6 channel to bring extracellular Ca +2 into the cell. Increased Ca +2 is taken up by mitochondria, which release Reactive Oxygen Species (ROS) and contribute to oxidative stress. BI 749327 can block TRPC6 channel activity and suppress oxidative stress. Meanwhile, hyper-activation of β2AR leads to endosomal β2AR loss, followed by endosomal loss of CFTR (-). Loss of CFTR results in (i) activation of TRADD and downstream activation of IKKαβ to drive NFκB; and (ii) further activation of CFTR-bound TRPC6. NFκB enters the nucleus and drives expression of proinflammatory cytokines IL8 and IL6. Both TRADD and PI3K pathways may be required for optimal NFκB activation, because LY294002 can block inflammation.

    Techniques Used: Blocking Assay, Activity Assay, Activation Assay, Expressing



    Similar Products

    cftr  (Alomone Labs)
    94
    Alomone Labs cftr
    Cftr, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    cftr - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    cftr inh 172  (Selleck Chemicals)
    93
    Selleck Chemicals cftr inh 172
    Cftr Inh 172, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr inh 172/product/Selleck Chemicals
    Average 93 stars, based on 1 article reviews
    cftr inh 172 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    cftr  (R&D Systems)
    93
    R&D Systems cftr
    (a & b) Representative I sc tracings of <t>CFTR-dependent</t> short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR <t>and</t> <t>β2AR</t> expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.
    Cftr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    cftr - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    couple cystic fibrosis 699 transmembrane conductance regulator cftr proteostasis  (Proteostasis Therapeutics)
    86
    Proteostasis Therapeutics couple cystic fibrosis 699 transmembrane conductance regulator cftr proteostasis
    (a & b) Representative I sc tracings of <t>CFTR-dependent</t> short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR <t>and</t> <t>β2AR</t> expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.
    Couple Cystic Fibrosis 699 Transmembrane Conductance Regulator Cftr Proteostasis, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/couple cystic fibrosis 699 transmembrane conductance regulator cftr proteostasis/product/Proteostasis Therapeutics
    Average 86 stars, based on 1 article reviews
    couple cystic fibrosis 699 transmembrane conductance regulator cftr proteostasis - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    anti cftr acl006  (Alomone Labs)
    94
    Alomone Labs anti cftr acl006
    (a & b) Representative I sc tracings of <t>CFTR-dependent</t> short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR <t>and</t> <t>β2AR</t> expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.
    Anti Cftr Acl006, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cftr acl006/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    anti cftr acl006 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    cftr modulators  (Vertex Pharmaceuticals)
    86
    Vertex Pharmaceuticals cftr modulators
    (a & b) Representative I sc tracings of <t>CFTR-dependent</t> short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR <t>and</t> <t>β2AR</t> expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.
    Cftr Modulators, supplied by Vertex Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr modulators/product/Vertex Pharmaceuticals
    Average 86 stars, based on 1 article reviews
    cftr modulators - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    cftr mrna lnp  (Moderna)
    86
    Moderna cftr mrna lnp
    (A) LNPs can package diverse cargos (pDNA, <t>mRNA/circRNA,</t> ASO, miRNA/siRNA, and CRISPR components). (B) After i.v. dosing, therapeutics face off-target biodistribution, immune clearance, serum nucleases, and extravasation. (C) Inside cells, uptake is followed by potential recycling vs endosomal escape; cytosolic cargos act via translation or RISC, whereas others (pDNA, Cas-gRNA, HDR templates) require nuclear entry. Adapted from Ref. under a CC BY 4.0 license ( http://creativecommons.org/licenses/by/4.0/ ).
    Cftr Mrna Lnp, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr mrna lnp/product/Moderna
    Average 86 stars, based on 1 article reviews
    cftr mrna lnp - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    rabbit anti cftr  (Alomone Labs)
    94
    Alomone Labs rabbit anti cftr
    (A) LNPs can package diverse cargos (pDNA, <t>mRNA/circRNA,</t> ASO, miRNA/siRNA, and CRISPR components). (B) After i.v. dosing, therapeutics face off-target biodistribution, immune clearance, serum nucleases, and extravasation. (C) Inside cells, uptake is followed by potential recycling vs endosomal escape; cytosolic cargos act via translation or RISC, whereas others (pDNA, Cas-gRNA, HDR templates) require nuclear entry. Adapted from Ref. under a CC BY 4.0 license ( http://creativecommons.org/licenses/by/4.0/ ).
    Rabbit Anti Cftr, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti cftr/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    rabbit anti cftr - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    cftr  (Altera Corp)
    86
    Altera Corp cftr
    (A) LNPs can package diverse cargos (pDNA, <t>mRNA/circRNA,</t> ASO, miRNA/siRNA, and CRISPR components). (B) After i.v. dosing, therapeutics face off-target biodistribution, immune clearance, serum nucleases, and extravasation. (C) Inside cells, uptake is followed by potential recycling vs endosomal escape; cytosolic cargos act via translation or RISC, whereas others (pDNA, Cas-gRNA, HDR templates) require nuclear entry. Adapted from Ref. under a CC BY 4.0 license ( http://creativecommons.org/licenses/by/4.0/ ).
    Cftr, supplied by Altera Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cftr/product/Altera Corp
    Average 86 stars, based on 1 article reviews
    cftr - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    primary rabbit anti hcftr  (R&D Systems)
    93
    R&D Systems primary rabbit anti hcftr
    (A) LNPs can package diverse cargos (pDNA, <t>mRNA/circRNA,</t> ASO, miRNA/siRNA, and CRISPR components). (B) After i.v. dosing, therapeutics face off-target biodistribution, immune clearance, serum nucleases, and extravasation. (C) Inside cells, uptake is followed by potential recycling vs endosomal escape; cytosolic cargos act via translation or RISC, whereas others (pDNA, Cas-gRNA, HDR templates) require nuclear entry. Adapted from Ref. under a CC BY 4.0 license ( http://creativecommons.org/licenses/by/4.0/ ).
    Primary Rabbit Anti Hcftr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary rabbit anti hcftr/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    primary rabbit anti hcftr - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    (a & b) Representative I sc tracings of CFTR-dependent short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR and β2AR expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: (a & b) Representative I sc tracings of CFTR-dependent short-circuit currents ( I sc ) were measured in Ussing chambers. (c) Representative Western blot images of total cellular CFTR and β2AR expression levels in treated dBCi cells after Ussing chamber analyses in ( a ). (d) Densitometric analyses showing B[a]P-induced reduction of both β2AR and CFTR expression in a dose-dependent manner. (e) The Pearson correlation coefficient (r) showing a significant positive relationship between B[a]P-inhibited β2AR and CFTR expression. All data were obtained from three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.01.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Western Blot, Expressing, Control

    Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of B[a]P. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.05; ** p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a ).

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of B[a]P. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; * p < 0.05; ** p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a ).

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Incubation, Control, Western Blot, Expressing

    Cells were treated with various concentrations of PM2.5 for 24 hr. ( a ) Cell viability was assessed with MTT assay. ( b ) IL-6 and IL-8 from the basolateral sides. ( c ) Representative Western blot images showing CFTR, β2AR, phospho-AKT (Ser473), AKT, phospho-NF-κB p65 (Ser536), NF-κB p65, and TRPC6 expression. All data are presented as the mean ± SD (n = 4). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; *, p < 0.05; ¥, p < 0.01; NS, no significance.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: Cells were treated with various concentrations of PM2.5 for 24 hr. ( a ) Cell viability was assessed with MTT assay. ( b ) IL-6 and IL-8 from the basolateral sides. ( c ) Representative Western blot images showing CFTR, β2AR, phospho-AKT (Ser473), AKT, phospho-NF-κB p65 (Ser536), NF-κB p65, and TRPC6 expression. All data are presented as the mean ± SD (n = 4). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; *, p < 0.05; ¥, p < 0.01; NS, no significance.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: MTT Assay, Western Blot, Expressing, Control

    Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of PM 2.5. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 6). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a). All Western analyses represent the results of three independent experiments, and β-actin was used for equal loading of protein.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: Both apical and basolateral sides of polarized 16HBE14o-cells (ALI for 8-10 days) were incubated with different concentrations of PM 2.5. Treated media from the apical sides were removed after 6-hr incubation, and cell treatment continued further for 18 hrs under ALI conditions. ( a ) Representative I sc tracings of CFTR-dependent short-circuit currents (I sc ) measured in Ussing chambers as the changes in response to Amiloride, IBMX/Forskolin, and CFTRinh-172. (b) Summary of changes in I sc is shown. Data represent the mean of three independent experiments, and each experiment was performed in duplication (n = 6). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01. ( c ) Representative Western blot images of β2AR and CFTR expression levels in treated cells after Ussing chamber analyses in ( a). All Western analyses represent the results of three independent experiments, and β-actin was used for equal loading of protein.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Incubation, Control, Western Blot, Expressing

    (a) Representative Western blot images of cell surface CFTR and β2AR expression in cells treated with DMSO or various concentrations of B[a]P. (b & c) Recycling assay of endocytosis CFTR and β2AR were analyzed by Western blot. Representative Western blot images of biotinylated CFTR and β2AR expression are shown. Cell samples treated without or with GSH ( lanes 1 and 2 ) were used as positive controls for biotinylation and GSH stripping processes, respectively. (d) A representative Western blot image showing ubiquitination of CFTR immunoprecipitates from cell lysates treated with different concentrations of B[a]P in the presence of 20 µM MG 132. All Western blot analyses represent the results of three independent experiments.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: (a) Representative Western blot images of cell surface CFTR and β2AR expression in cells treated with DMSO or various concentrations of B[a]P. (b & c) Recycling assay of endocytosis CFTR and β2AR were analyzed by Western blot. Representative Western blot images of biotinylated CFTR and β2AR expression are shown. Cell samples treated without or with GSH ( lanes 1 and 2 ) were used as positive controls for biotinylation and GSH stripping processes, respectively. (d) A representative Western blot image showing ubiquitination of CFTR immunoprecipitates from cell lysates treated with different concentrations of B[a]P in the presence of 20 µM MG 132. All Western blot analyses represent the results of three independent experiments.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Western Blot, Expressing, Stripping Membranes, Ubiquitin Proteomics

    ALI cells were treated with DMSO, 100 ng/mL PM 2.5, 10 µM LY 294002 ± PM 2.5, or 10 µM LY 303511 ± PM 2.5 for 24 hrs. ( a ) IL-6 and IL-8 from the basolateral sides were determined using the DuoSet® ELISA kits. Data are presented as the mean ± SD (n=3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing all treatments to the DMSO control, or PM 2.5 to PM 2.5 ± LY 294002 or LY 303511; *, p < 0.01. ( b ) Representative Western blot images showing CFTR and β-actin expression. β-actin was used to ensure equal loading of protein. All data were obtained from three independent experiments, and each experiment was analyzed in duplication.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: ALI cells were treated with DMSO, 100 ng/mL PM 2.5, 10 µM LY 294002 ± PM 2.5, or 10 µM LY 303511 ± PM 2.5 for 24 hrs. ( a ) IL-6 and IL-8 from the basolateral sides were determined using the DuoSet® ELISA kits. Data are presented as the mean ± SD (n=3). Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing all treatments to the DMSO control, or PM 2.5 to PM 2.5 ± LY 294002 or LY 303511; *, p < 0.01. ( b ) Representative Western blot images showing CFTR and β-actin expression. β-actin was used to ensure equal loading of protein. All data were obtained from three independent experiments, and each experiment was analyzed in duplication.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Enzyme-linked Immunosorbent Assay, Control, Western Blot, Expressing

    ( a ) Fluo-4-AM fluorescence intensity traces obtained 24 hours after treatment with B[a]P and stimulated with assay buffer containing 1 mM Ca +2 . ( b ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 1 mM Ca +2 . ( c & d ) Representative Western blot images of β2AR and TRPC6 expression levels in treated cell in ( a ) and respective densitometric analyses. ( e ) The Pearson correlation coefficient (r) showing a significant negative relationship between β2AR and TRPC6 expression caused by B[a]P treatment. ( f ) Fluo-4AM fluorescence intensity traces in 16HBE14o-cells were obtained before and after addition of 2 mM Ca +2 in the presence or absence of 5µM BI 749327. ( g ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 2 mM Ca +2 . ( h ) Representative western blotting analyses of CFTR expression in corresponding treated cells. All data represent the mean of three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P ± BI 749327 treatments to the DMSO control; ¥, p<0.05, * p < 0.01.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: ( a ) Fluo-4-AM fluorescence intensity traces obtained 24 hours after treatment with B[a]P and stimulated with assay buffer containing 1 mM Ca +2 . ( b ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 1 mM Ca +2 . ( c & d ) Representative Western blot images of β2AR and TRPC6 expression levels in treated cell in ( a ) and respective densitometric analyses. ( e ) The Pearson correlation coefficient (r) showing a significant negative relationship between β2AR and TRPC6 expression caused by B[a]P treatment. ( f ) Fluo-4AM fluorescence intensity traces in 16HBE14o-cells were obtained before and after addition of 2 mM Ca +2 in the presence or absence of 5µM BI 749327. ( g ) Corresponding histograms summarize the mean changes in RFU (F 1 – F 0 ) after stimulation by 2 mM Ca +2 . ( h ) Representative western blotting analyses of CFTR expression in corresponding treated cells. All data represent the mean of three independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P ± BI 749327 treatments to the DMSO control; ¥, p<0.05, * p < 0.01.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Fluorescence, Western Blot, Expressing, Control

    ( a ) After 24 hr treatment, fluorescence intensity traces obtained using the fluo-4 AM when DMSO- or PM 2.5-treated 16HBE14o-cellswere stimulated with assay buffer containing 2 mM Ca. Each trace is the mean of three independent experiments with standard deviations (vertical bars). ( b ) Corresponding histograms summarize the mean area under the curve (AUC) after stimulation by 2 mM Ca. ( c ) Representative Western blot images of CFTR, β2AR and TRPC6 expression levels in treated cell in ( a ). All data were obtained from four independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the PM 2.5 treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: ( a ) After 24 hr treatment, fluorescence intensity traces obtained using the fluo-4 AM when DMSO- or PM 2.5-treated 16HBE14o-cellswere stimulated with assay buffer containing 2 mM Ca. Each trace is the mean of three independent experiments with standard deviations (vertical bars). ( b ) Corresponding histograms summarize the mean area under the curve (AUC) after stimulation by 2 mM Ca. ( c ) Representative Western blot images of CFTR, β2AR and TRPC6 expression levels in treated cell in ( a ). All data were obtained from four independent experiments. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the PM 2.5 treatments to the DMSO control; ¥, p < 0.05; *, p < 0.01.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Fluorescence, Western Blot, Expressing, Control

    ( a ) The lung parenchyma from two ferrets were sliced into several sections as shown. Arrows indicate the tracheobronchial tubes. All tissue sections were incubating with DMSO (control), 10 µM B[a]P, or 100 ng/mL PM 2.5 in Pneumacult-EX Plus Basal media for 24 hrs. ( b ) IL 6 secretion was determined using the ferret ELISA kit. Data represent the mean of 6 independent sections. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; ¥, p < 0.05 (n = 6). ( c ) Representative western blotting images show reduction of CFTR, and β2AR and elevation of TRPC6 expression in explants under these treatments.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: ( a ) The lung parenchyma from two ferrets were sliced into several sections as shown. Arrows indicate the tracheobronchial tubes. All tissue sections were incubating with DMSO (control), 10 µM B[a]P, or 100 ng/mL PM 2.5 in Pneumacult-EX Plus Basal media for 24 hrs. ( b ) IL 6 secretion was determined using the ferret ELISA kit. Data represent the mean of 6 independent sections. Statistical p values were determined with a one-way ANOVA, followed by the Tukey post-hoc test comparing the B[a]P or PM 2.5 treatments to the DMSO control; ¥, p < 0.05 (n = 6). ( c ) Representative western blotting images show reduction of CFTR, and β2AR and elevation of TRPC6 expression in explants under these treatments.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Control, Enzyme-linked Immunosorbent Assay, Western Blot, Expressing

    PM 2.5 or the PM 2.5 toxin B[a]P initially acts as an irreversible β2AR agonist to hyperactivate the PI3K signaling pathway. PLC, acting on PIP2, releases DAG. DAG activates the TRPC6 channel to bring extracellular Ca +2 into the cell. Increased Ca +2 is taken up by mitochondria, which release Reactive Oxygen Species (ROS) and contribute to oxidative stress. BI 749327 can block TRPC6 channel activity and suppress oxidative stress. Meanwhile, hyper-activation of β2AR leads to endosomal β2AR loss, followed by endosomal loss of CFTR (-). Loss of CFTR results in (i) activation of TRADD and downstream activation of IKKαβ to drive NFκB; and (ii) further activation of CFTR-bound TRPC6. NFκB enters the nucleus and drives expression of proinflammatory cytokines IL8 and IL6. Both TRADD and PI3K pathways may be required for optimal NFκB activation, because LY294002 can block inflammation.

    Journal: bioRxiv

    Article Title: PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling

    doi: 10.64898/2026.04.21.719931

    Figure Lengend Snippet: PM 2.5 or the PM 2.5 toxin B[a]P initially acts as an irreversible β2AR agonist to hyperactivate the PI3K signaling pathway. PLC, acting on PIP2, releases DAG. DAG activates the TRPC6 channel to bring extracellular Ca +2 into the cell. Increased Ca +2 is taken up by mitochondria, which release Reactive Oxygen Species (ROS) and contribute to oxidative stress. BI 749327 can block TRPC6 channel activity and suppress oxidative stress. Meanwhile, hyper-activation of β2AR leads to endosomal β2AR loss, followed by endosomal loss of CFTR (-). Loss of CFTR results in (i) activation of TRADD and downstream activation of IKKαβ to drive NFκB; and (ii) further activation of CFTR-bound TRPC6. NFκB enters the nucleus and drives expression of proinflammatory cytokines IL8 and IL6. Both TRADD and PI3K pathways may be required for optimal NFκB activation, because LY294002 can block inflammation.

    Article Snippet: All antibodies were purchased commercially. β-actin (Sigma, A5441); CFTR (R&D Systems, MAB1660); CFTR (SCBT, sc-376683); β2AR (Novus Biologicals, NBP261710); TRADD (SCBT, sc-46653); TNFR1 (Cell Signaling, 3736), IKKβ (SCBT, sc-8014); IκBα (Cell Signaling, 9242); phospho-IκBα Ser32/36 (Cell Signaling, 9246); phospho-NFκB p65 Ser276 (Cell Signaling, 3037); NFκB p65 (Cell Signaling, 8242); phospho-IKKα/β Ser176/180 (Cell Signaling, 2697); IKKα (Cell Signaling, 11930); AKT (Cell Signaling, 9272); phosphor-AKT Ser473 (Cell Signaling, 9271); TRPC6 (Protein Tech, 18236-1-AP); and Ubiquitin (Protein Tech, 80992-1-RR).

    Techniques: Blocking Assay, Activity Assay, Activation Assay, Expressing

    (A) LNPs can package diverse cargos (pDNA, mRNA/circRNA, ASO, miRNA/siRNA, and CRISPR components). (B) After i.v. dosing, therapeutics face off-target biodistribution, immune clearance, serum nucleases, and extravasation. (C) Inside cells, uptake is followed by potential recycling vs endosomal escape; cytosolic cargos act via translation or RISC, whereas others (pDNA, Cas-gRNA, HDR templates) require nuclear entry. Adapted from Ref. under a CC BY 4.0 license ( http://creativecommons.org/licenses/by/4.0/ ).

    Journal: Materials Today Bio

    Article Title: Programmable lipid nanoparticles for RNA therapeutics: Design principles and clinical translation

    doi: 10.1016/j.mtbio.2026.102774

    Figure Lengend Snippet: (A) LNPs can package diverse cargos (pDNA, mRNA/circRNA, ASO, miRNA/siRNA, and CRISPR components). (B) After i.v. dosing, therapeutics face off-target biodistribution, immune clearance, serum nucleases, and extravasation. (C) Inside cells, uptake is followed by potential recycling vs endosomal escape; cytosolic cargos act via translation or RISC, whereas others (pDNA, Cas-gRNA, HDR templates) require nuclear entry. Adapted from Ref. under a CC BY 4.0 license ( http://creativecommons.org/licenses/by/4.0/ ).

    Article Snippet: VX-522 , Vertex/Moderna , CFTR mRNA (LNP) , Cystic fibrosis (modulator-ineligible) , Nebulized LNP for lung delivery , Inhaled , Ph1/2 ongoing; dose-escalation adjustments in 2025 , NCT05668741.

    Techniques: CRISPR